Quick Answer
Acurx Pharmaceuticals, Inc. reported Net Income of -$7.97 million for fiscal year 2025.
Acurx Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.97M | +43.5% |
| 2024 | -$14.10M | +3.3% |
| 2023 | -$14.58M | -20.5% |
| 2022 | -$12.09M | +5.1% |
| 2021 | -$12.75M | -177.1% |
| 2020 | -$4.60M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.99M | +29.4% | +11.3% |
| June 30, 2025 | -$2.25M | +45.5% | -4.5% |
| March 31, 2025 | -$2.15M | +50.9% | +23.8% |
| September 30, 2024 | -$2.82M | +9.4% | +31.5% |
| June 30, 2024 | -$4.12M | -19.6% | +5.8% |
| March 31, 2024 | -$4.38M | -50.8% | -40.5% |
| September 30, 2023 | -$3.11M | +12.0% | +9.6% |
| June 30, 2023 | -$3.45M | -31.5% | -18.7% |
- Acurx Pharmaceuticals, Inc. showed an increase of +43.5% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Acurx Pharmaceuticals, Inc.’s net income has declined by 73.2% (from -$4.60 million to -$7.97 million).
- The most recent figure is from Acurx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: